跳至主要内容
临床试验/NCT04988321
NCT04988321已完成不适用

Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2021年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
2
主要终点
Change in bodily and emotional perception of pain (BEEP) score

研究概览

简要总结

The purpose of the study is to determine the effects of a newer form of non-invasive brain stimulation (called transcranial magnetic stimulation or TMS) as a treatment in patients with painful diabetic neuropathy to examine its effects on their understanding of their pain experience.

详细描述

The proposed brain stimulation technique in this study is an investigational procedure that has not been approved by the U.S. FDA for treating pain linked to diabetic neuropathy, but it has been approved to treat depression. The study will use surveys to monitor how participant's body changes as their understanding of their pain experience changes. Participants will be randomized (like the flip of a coin) to receive brain stimulation at one of two brain regions which are involved in the processing and understanding of the pain experience.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with type II Diabetes Mellitus.
  • Age 18-75 years.
  • Diagnosed by a Physician with diabetic neuropathy/ distal symmetric polyneuropathy/ diabetic polyneuropathy.
  • Patients under physician care at Virginia Commonwealth University Health Systems in the Neurology Clinic/ Neurology Department and the Endocrinology Clinic
  • Neuropathic pain for at least 3 months.
  • Neuropathic pain signs and symptoms identified using Pain DETECT questionnaire.
  • Current pain score ≥3 or higher (0='no pain' and 10='worst possible pain').
  • Pain Medication dosage stable for at least 4 weeks

排除标准

  • Non-neuropathic chronic pain
  • Another concurrent cause of neuropathic pain
  • Any history of epilepsy, drug-resistant migraine, and/or any presence of ferromagnetic implant, cardiac pacemakers, implanted insulin pumps, neurostimulators, cochlear implants and surgical clips or medical pumps.
  • Limited English proficiency
  • Pregnant patients

结局指标

主要结局

Change in bodily and emotional perception of pain (BEEP) score

时间窗: Baseline to the end of the procedure, about 2.25 hours

The BEEP questionnaire is a self-report questionnaire measuring the impact of chronic pain on daily life. It has 23 items on a 0-5 Likert scale that assesses three pain dimensions, namely the emotional reaction to pain, the limitations to daily life caused by pain and the interference caused by pain in personal and social functioning. Responses are summed to yield a single BEEP score.

Change in Norfolk Quality of Life-Diabetic Neuropathy (QOL-DN) score

时间窗: Baseline to the end of the procedure, about 2.25 hours

The QOL-DN is questionnaire is an instrument to assess quality of life in patients with diabetic polyneuropathy. It is comprised of 35 items and yields a Total QOL score.

次要结局

  • Change in cortical inhibition (CI)(Baseline to the end of the procedure, about 2.25 hours)
  • Change in corticospinal excitability (CE)(Baseline to the end of the procedure, about 2.25 hours)
  • Change in pain threshold - Offset Analgesia (OA)(Baseline to the end of the procedure, about 2.25 hours)
  • Change in pain threshold - conditioned pain modulation (CPM)(Baseline to the end of the procedure, about 2.25 hours)
  • Change in pain threshold - Temporal Summation of Pain (TSP)(Baseline to the end of the procedure, about 2.25 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验